|
Cardiorentis initiates first-ever acute heart failure Phase III clinical trial …
PharmiWeb.com (press release) Cardiorentis has initiated the first-ever acute heart failure (AHF) Phase III trial to be specifically designed to assess the effect of early treatment on cardiovascular mortality. TRUE-AHF (TRial of Ularitide’s Efficacy and safety in patients with … |
Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger … – PR Newswire (press release)
|
Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger …
PR Newswire (press release) 11, 2013 /PRNewswire/ — Life Technologies Corporation (NASDAQ: LIFE) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. The development … |
Cardiorentis initiates first-ever acute heart failure Phase III clinical trial … – PR Newswire (press release)
|
Cardiorentis initiates first-ever acute heart failure Phase III clinical trial …
PR Newswire (press release) Cardiorentis has initiated the first-ever acute heart failure (AHF) Phase III trial to be specifically designed to assess the effect of early treatment on cardiovascular mortality. TRUE-AHF (TRial of Ularitide’s Efficacy and safety in patients with … |
Welsh Paralympian Backs Organ Donor Campaign – ITV News
ITV NewsWelsh Paralympian Backs Organ Donor CampaignITV NewsA shortage of donor organs means that about three people die each month in Wales while waiting for a transplant. Organs that can be donated include hearts, kidneys, livers and lungs. Signing t…
Symposium to discuss new techniques for assessing risk of acute kidney injury – News-Medical.net
Symposium to discuss new techniques for assessing risk of acute kidney injuryNews-Medical.netLeading critical care experts will discuss new techniques for assessing risk of acute kidney injury (AKI) at an educational symposium to be held at the Eightee…
Modified virus triples cancer survival time – Times of India
Times of IndiaModified virus triples cancer survival timeTimes of India… hope to liver cancer patients. Researchers have found that a genetically engineered version of the vaccinia virus tripled the average survival time of people with a severe form …
Researchers discover how some natural antibodies are able to stop flu – Medical Xpress
|
Researchers discover how some natural antibodies are able to stop flu
Medical Xpress (Medical Xpress)—Researchers with the Scripps Institute have discovered that three naturally occurring antibodies are able to overcome flu mutations by attaching to a non-changing protein in the flu virus. As they describe in their paper published in … SCRIPPS FINDS WAY TO FIGHT FLU VIRUSU-T San Diego |
Mandela feeling better now, Zuma says – Times of India
Times of IndiaMandela feeling better now, Zuma saysTimes of IndiaMandela, 94, was at home in Johannesburg, where he has been recovering after an 18-day stay in hospital last December for a lung infection and gallstone surgery. Zuma met Mandela on his w…
Daily Five: A Pasta Dinner to Benefit Cindy Grant – Patch.com
Daily Five: A Pasta Dinner to Benefit Cindy GrantPatch.com3. The Mystic Hoxie Firehouse is hosting a family style pasta dinner to benefit Cindy Grant, an emergency dispatcher fighting multiple myeloma. She needs a stem cell transplant. The dinner will …
Tweaked protein prevents diastolic heart failure – Newstrack India
Tweaked protein prevents diastolic heart failureNewstrack IndiaWashington, Feb 11 (IANS) Researchers have identified and tweaked a specific protein molecule, parvalbumin, to prevent diastolic heart failure when its pumping mechanism goes haywire. Diast…